MedTrace Logo

BIP CVC in Access Center at Danderyd Hospital, Stockholm, Sweden

NCT03976557 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 19

Last updated 2021-01-22

No results posted yet for this study

Summary

Primary objective of the study is to establish the incidence of all any catheter related complications in BIP CVC and standard CVC groups in patients requiring CVC.

(CVC - Central Venous Catheter; BIP - Bactiguard Infection Protection)

Conditions

  • Vascular Access Complication
  • Catheter-Related Infections
  • Catheter Thrombosis
  • Catheter Blockage
  • Catheter Complications
  • Catheter Site Discomfort
  • Catheter Bacteraemia

Interventions

DEVICE

BIP CVC

Central venous access with noble metal coated CVC

DEVICE

Standard CVC

Central venous access with standard uncoated CVC

Sponsors & Collaborators

  • Danderyd Hospital

    collaborator OTHER

  • Bactiguard AB

    lead INDUSTRY

Principal Investigators

  • Jan Jakobsson, Prof · Danderyd Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-04-11
Primary Completion
2019-12-18
Completion
2019-12-18

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03976557 on ClinicalTrials.gov